---
schema_version: "secwatch.filing_event.v1"
accession: "0001933414-24-000008"
form_type: "8-K"
ticker: "MLYS"
cik: "0001933414"
company_name: "Mineralys Therapeutics, Inc."
filed_at: "2024-04-04T23:59:59+00:00"
generated_at: "2026-06-04T02:31:51.374692+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Director Alexander Asam not standing for re-election at 2024 annual meeting

## Summary
- Alexander Asam, Ph.D. informed the Board on March 29, 2024 of his decision.
- He will not stand for re-election when his term expires at the 2024 annual meeting.
- Asam stated the decision was not due to any disagreement with the Company or management.

## SEC filing metadata
- accession: 0001933414-24-000008
- form_type: 8-K
- ticker: MLYS
- cik: 0001933414
- company_name: Mineralys Therapeutics, Inc.
- filed_at: 2024-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1933414/000193341424000008/0001933414-24-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1933414/000193341424000008/mlys-20240329.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001933414-24-000008
- JSON: https://secwatch.observer/filing/0001933414-24-000008.json
- Plain text: https://secwatch.observer/filing/0001933414-24-000008.txt

## Key facts
- Executive change
  Alexander Asam departed as Director at Mineralys Therapeutics, Inc..
  - Action: not stand for re-election
  - Role: Director
  source text: On March 29, 2024, Alexander Asam, Ph.D. informed the Board of Directors (the “Board”) of Mineralys Therapeutics, Inc. (the “Company”) of his decision not to stand for re-election to the Board when his current term expires at the Company’s 2024 annual meeting of stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1933414/000193341424000008/0001933414-24-000008-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.